profit from every ₹100 of sales.
₹0₹100
HealthCare Global Enterprises
₹569.05-1.16% today
-19.6% in 1 year
1-year low ₹521.751-year high ₹745.25
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹6.55 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What HealthCare Global Enterprises sold, what it kept, and what it did with the cash.
Sales went from $16.8 billion in 2023 to $25.4 billion in 2026, with $138 million of profit last year.
SalesProfit
HealthCare Global Enterprises vs. similar companies
HealthCare Global Enterprises grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| HealthCare Global Enterprises | 6.6× · Cheap | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads HealthCare Global Enterprises's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 16,760 | 18,899 | 22,181 | 25,384 | |
| 8,763 | 9,799 | 11,559 | 12,971 | |
| 1,683 | 1,574 | 1,759 | 2,216 | |
| 3,027 | 3,428 | 4,229 | 4,477 | |
| 293 | 482 | 444 | 138 | |
| 2.09 | 3.41 | 3.12 | 0.96 | |
| 52.3% | 51.9% | 52.1% | 51.1% | |
| 10.0% | 8.3% | 7.9% | 8.7% | |
| 1.8% | 2.5% | 2.0% | 0.5% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 23,160 | 27,075 | 35,432 | 39,225 |
| Cash | 1,746 | 2,726 | 2,359 | 5,361 |
| Total debt | 9,012 | 12,744 | 18,372 | 17,354 |
| Total liabilities | 14,466 | 18,424 | 25,532 | 25,123 |
| 8,605 | 8,258 | 9,224 | 13,320 | |
| 140 | 141 | 142 | 143 | |
| 5.9% | 6.0% | 5.7% | 5.0% | |
| 3.4% | 5.8% | 4.8% | 1.0% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 2,516 | 2,846 | 3,171 | 3,471 | |
| 1,332 | 1,857 | 2,089 | 2,921 | |
| 1,184 | 989 | 1,082 | 550 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 65 | 78 | 65 | -566 |
Valuation
- 6.6×
- –
- –
- 7.1×
- 0.0×
- 1.6×
- 2.9×
- 61.0%
- 15.3%
- –
Profitability
- 51.1%
- 8.7%
- 0.5%
- –
- 5.0%
- 5.7%
- –
- –
- –
- –
Growth
- +14.8%
- −22.8%
- –
- –
- +0.8%
Financial health
- 2.7×
- 1.30
- –
- 1.2×
- 1.12
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 49%of 946
Top 50%of 872
Top 5%of 563
Top 39%of 868
Top 1%of 986
News
Gabelli Healthcare & Wellness Trust raises dividend by 17.6% to $0.20Seeking Alpha · Nov 11, 2026Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink ItYahoo Finance · Nov 11, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14%Seeking Alpha · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
46No pass
Benjamin Graham
57No pass
Philip Fisher
43No pass
Peter Lynch
26No pass
Joel Greenblatt
58No pass
Charlie Munger
24No pass
Terry Smith
28No pass
Questions about HealthCare Global Enterprises
Is HealthCare Global Enterprises a good stock to buy?
A business with weak numbers, and the price looks low. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the HealthCare Global Enterprises AI analysis
What does HealthCare Global Enterprises do?
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. It is in Medical Care Facilities, based in Bengaluru, India.
Is HealthCare Global Enterprises stock halal?
Yes. HealthCare Global Enterprises passes our halal screen: its business is permitted and its debt is 20% of its market value, under the 30% limit. How we check
How has HealthCare Global Enterprises stock done over the past year?
Down 19.6% over the past twelve months, to ₹569.05. It traded between ₹521.75 and ₹745.25 and is 23.6% below its high.
Who are HealthCare Global Enterprises's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with HealthCare Global Enterprises's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.